Search by Drug Name or NDC
NDC 00555-0779-04 Medroxyprogesterone Acetate 10 mg/1 Details
Medroxyprogesterone Acetate 10 mg/1
Medroxyprogesterone Acetate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is MEDROXYPROGESTERONE ACETATE.
MedlinePlus Drug Summary
Medroxyprogesterone is used to treat abnormal menstruation (periods) or irregular vaginal bleeding. Medroxyprogesterone is also used to bring on a normal menstrual cycle in women who menstruated normally in the past but have not menstruated for at least 6 months and who are not pregnant or undergoing menopause (change of life). Medroxyprogesterone is also used to prevent overgrowth of the lining of the uterus (womb) and may decrease the risk of cancer of the uterus in patients who are taking estrogen. Medroxyprogesterone is in a class of medications called progestins. It works by stopping the growth of the lining of the uterus and by causing the uterus to produce certain hormones.
Related Packages: 00555-0779-04Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Medroxyprogesterone
Product Information
| NDC | 00555-0779 |
|---|---|
| Product ID | 0555-0779_12e9b52f-a3dc-4cb6-9e1c-0e02765402e6 |
| Associated GPIs | 26000020200315 |
| GCN Sequence Number | 003271 |
| GCN Sequence Number Description | medroxyprogesterone acetate TABLET 10 MG ORAL |
| HIC3 | G2A |
| HIC3 Description | PROGESTATIONAL AGENTS |
| GCN | 11260 |
| HICL Sequence Number | 001442 |
| HICL Sequence Number Description | MEDROXYPROGESTERONE ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | Medroxyprogesterone Acetate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Medroxyprogesterone Acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/1 |
| Substance Name | MEDROXYPROGESTERONE ACETATE |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Pharmaceutical Class | Progesterone Congeners [CS], Progestin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040159 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00555-0779-04 (00555077904)
| NDC Package Code | 0555-0779-04 |
|---|---|
| Billing NDC | 00555077904 |
| Package | 500 TABLET in 1 BOTTLE (0555-0779-04) |
| Marketing Start Date | 1996-12-04 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.14437 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | MEDROXYPROGESTERONE 10 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |